Tag: Sun Pharma

spot_imgspot_img

Tildrakizumab for Treatment of Moderate-to-Severe Plaque Psoriasis: Could Sun Pharma’s ‘Ilumya’ be a Better Option?

Tildrakizumab is being marketed by Sun Pharma under the trade name Ilumya, and has been approved by FDA in March 2018 after analysis of...

Sun Pharma Presents Data, Offering Insights for Treating People with or at Risk of Skin Cancer

Sun Pharma has presented data on ODOMZO® (drug for treatment of skin cancer) and LEVULAN® KERASTICK® + BLU-U®, (for treating precancerous lesions) supporting safety...

Stay in touch:

255,324FansLike
128,657FollowersFollow
97,058SubscribersSubscribe

Newsletter

Don't miss

What will happen to our home galaxy Milky Way in future? 

In about six billion years from now, our home...

COVID-19 in 2025  

The unprecedented COVID-19 pandemic spanning over three years claimed...

UK’s First Birth Following Living-donor Uterine Transplantation

The woman who had undergone the first living-donor uterus...

Qfitlia (Fitusiran): A Novel siRNA-based Treatment for Haemophilia  

Qfitlia (Fitusiran), a novel siRNA-based treatment for haemophilia has...

JWST’s Deep Field Observations Contravene Cosmological Principle

James Webb Space Telescope’s deep field observations under JWST...
spot_img